Pediatric drugs are a special class of drugs which are prescribed to
children and infants for different diseases. These drugs are
recommended in various conditions such as asthma, anorexia, birth
defects, cancer in children, growth deficiencies, juvenile diabetes,
attention deficit hyperactivity disorder, and others.
Report Overview @
https://www.transparencymarketresearch.com/pediatric-drugs-market.html
Various acts have been passed to control pediatric drugs such as Best
Pharmaceuticals for Children Act (BPCA) and the Pediatric Research
Equity Act (PREA). These acts have been introduced to increase the
investments on R&D for pediatric drugs and to increase the drugs
count prescribed for children and infants.
Pediatric drugs are categorized in three segments namely pediatric
clinical pharmacology, pediatric pharmacotherapy and pediatric
pharmacy. Pediatric pharmacotherapy focuses on those drugs which will
behave differently in children and adults. Pediatric clinical
pharmacology includes those drugs which are helpful for mental and
physical growth. Pediatric pharmacy includes all those drugs which
are specifically meant for children.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1724
To treat various disease conditions different drugs are prescribed
such as acetaminophen, fentanyl, ibuprofen, naloxone and methadone
are given as analgesics. In addition, cefazolin, ampicillin and
meropenem are prescribed to treat microbial infections whereas
clonidine and etomidate are recommended for sedative effect. Various
other drugs are tramadole, oxycodone, codeine, lorazepam and
gabapentin.
Growing concerns globally, amongst parents has assisted the growth of
this segment. Moreover, governments worldwide are funding and
initiating various national programs to support use of drugs to curb
infant and child mortality rates. Rise in disposable income along
with awareness in people has augmented the growth of pediatric drugs
in developed nations such as U.S. and Europe. In addition, rising
incidence of disease conditions such as obesity, diabetes and
hypertension in children have also contributed in its growth. Despite
various developments, low disposable income and unawareness in
developing nations are hindering the growth of this market. Moreover,
side effects such as anxiety, headache and fatigue are also
restricting its growth.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=1724<ype=S
Some of the major market players of pediatric drug include InfaCare
Inc., Medeira Therapeutics, Crucell Biologics Inc., Actelion Pharma
ceuticals Ltd. and other significant players.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment